BellRing Brands vs Herbalife
BRBR and HLF side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BRBR and HLF compare
Herbalife is the larger company, worth 1.3 times as much as BellRing Brands ($1.4B against $1.1B).
On earnings, BellRing Brands is cheaper: it trades at 6.5× trailing earnings, against 8.4× for Herbalife.
BellRing Brands grew revenue faster over the last twelve months (5.9% versus 5.5% for Herbalife).
BellRing Brands keeps more of each dollar of sales as profit, with a net margin of 7.3% compared with 3.2% at Herbalife.
BellRing Brands scores higher on the StockData Score (16 against 10 for Herbalife), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BRBR | HLF |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $1.4B |
| Share price | $9.17 | $13.05 |
| Change, 1 year | −70.3% | 62.7% |
| Change, 5 years | −65.1% | −69.8% |
| Beta (5Y) | 0.61 | 0.62 |
| Employees | 530 | 8,500 |
| StockData Score | ||
| Total score | 16 (better) | 10 |
| Valuation score | 6 (better) | 5 |
| Growth score | 4 (better) | 2 |
| Performance score | 3 (better) | 2 |
| Health score | 3 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 6.5× (better) | 8.4× |
| P/S | 0.5× | 0.3× (better) |
| EV/EBITDA | 6.5× | 4.9× (better) |
| P/FCF | 4.7× | 4.2× (better) |
| PEG | 0.27 | – |
| FCF yield | 21.1% | 23.6% (better) |
| Fair value | $35.42 | $27.91 |
| Margin of safety | 74.1% (better) | 53.2% |
| Growth | ||
| Revenue growth (TTM) | 5.9% (better) | 5.5% |
| Revenue growth, 5Y average | 18.6% (better) | −1.9% |
| Net income growth (TTM) | −24.9% (better) | −49.5% |
| EPS growth (TTM) | −18.9% (better) | −51.1% |
| EPS growth, 5Y average | 22.9% (better) | −4.5% |
| Profitability | ||
| Gross margin | 28.6% | 77.7% (better) |
| Operating margin | 13.3% (better) | 9.5% |
| Net margin | 7.3% (better) | 3.2% |
| FCF margin | 9.6% (better) | 6.2% |
| Return on invested capital | 36.4% (better) | 32.6% |
| Financial health | ||
| Net debt / EBITDA | 3.27 | 2.68 (better) |
| Interest coverage | – | 2.6× |
| Current ratio | 2.25 (better) | 1.20 |
| Altman Z-score | 4.64 (better) | 2.45 |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | 32.3% (better) | 0.83% |
| Shareholder yield | 32.3% (better) | 0.83% |
| Ownership | ||
| Held by institutions | 114% | 100% |
| Held by insiders | 1.5% | 3.2% |
| Insider net buying, 12 months | −$39.3K (better) | −$2.4M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 10.7% | 8.0% |
Go deeper
- BRBR stock overview
- BRBR income statement
- BRBR valuation and score
- HLF stock overview
- HLF income statement
- HLF valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.